Literature DB >> 16799030

Structure-function relationships using confocal scanning laser ophthalmoscopy, optical coherence tomography, and scanning laser polarimetry.

Christopher Bowd1, Linda M Zangwill, Felipe A Medeiros, Ivan M Tavares, Esther M Hoffmann, Rupert R Bourne, Pamela A Sample, Robert N Weinreb.   

Abstract

PURPOSE: To assess the strength of the association between retinal nerve fiber layer (RNFL) thickness and optic disc topography measured with confocal retinal tomography (HRT II; Heidelberg Engineering, Dossenheim, Germany), optical coherence tomography (StratusOCT; Carl Zeiss Meditec, Inc., Dublin, CA), and scanning laser polarimetry (GDx with variable corneal compensator, VCC; Carl Zeiss Meditec, Inc.), and visual field (VF) sensitivity and to determine whether this association is better expressed as a linear or nonlinear function.
METHODS: One hundred twenty-seven patients with glaucoma or suspected glaucoma and 127 healthy eyes from enrollees in the Diagnostic Innovations in Glaucoma Study (DIGS) were tested on HRT II, StratusOCT, GDx VCC, and standard automated perimetry (SAP, with the Swedish Interactive Thresholding Algorithm [SITA]) within 3 months of each other. Linear and logarithmic associations between RNFL thickness (HRT II, StratusOCT, and GDx VCC) and neuroretinal rim area (HRT II) and SAP sensitivity expressed in decibels were determined globally and for six RNFL/optic disc regions (inferonasal, inferotemporal, temporal, superotemporal, superonasal, and nasal) and six corresponding VF regions (superior, superonasal, nasal, inferonasal, inferior, and temporal).
RESULTS: The associations (R2) between global and regional RNFL/optic disc measurements and VF sensitivity ranged from <0.01 (temporal RNFL, nasal VF, and nasal RNFL, temporal VF; linear and logarithmic associations) to 0.26 (inferotemporal RNFL, superonasal VF; logarithmic association) for HRT II; from 0.02 (temporal RNFL, nasal VF; linear association) to 0.38 (inferotemporal RNFL, superonasal VF; logarithmic association) for OCT; and from 0.03 (temporal RNFL, nasal VF; linear association) to 0.21 (inferotemporal RNFL, superonasal VF; logarithmic association) for GDx. Structure-function relationships generally were strongest between the inferotemporal RNFL-optic disc sector and the superonasal visual field and were significantly stronger for StratusOCT RNFL thickness than for other instruments in this region. Global associations (linear and logarithmic) were significantly stronger using OCT compared with HRT. In most cases, logarithmic fits were not significantly better than linear fits when visual sensitivity was expressed in log units (i.e., decibels).
CONCLUSIONS: These results suggest that structure-function associations are strongest with StratusOCT measurements and are similar between HRT II and GDx VCC and these associations are generally no better expressed logarithmically than linearly when healthy, suspect, and glaucomatous eyes are considered.

Entities:  

Mesh:

Year:  2006        PMID: 16799030     DOI: 10.1167/iovs.05-1489

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  63 in total

1.  Relationships between visual field sensitivity and spectral absorption properties of the neuroretinal rim in glaucoma by multispectral imaging.

Authors:  Jonathan Denniss; Ingo Schiessl; Vincent Nourrit; Cecilia H Fenerty; Ramesh Gautam; David B Henson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

2.  Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function.

Authors:  Robert N Weinreb; Paul L Kaufman
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-04       Impact factor: 4.799

3.  Retinal ganglion cell and inner plexiform layer thickness measurements in regions of severe visual field sensitivity loss in patients with glaucoma.

Authors:  A L de A Moura; A S Raza; M A Lazow; C G De Moraes; D C Hood
Journal:  Eye (Lond)       Date:  2012-06-15       Impact factor: 3.775

4.  Structure-function relationships using the Cirrus spectral domain optical coherence tomograph and standard automated perimetry.

Authors:  Mauro T Leite; Linda M Zangwill; Robert N Weinreb; Harsha L Rao; Luciana M Alencar; Felipe A Medeiros
Journal:  J Glaucoma       Date:  2012-01       Impact factor: 2.503

5.  Understanding disparities among diagnostic technologies in glaucoma.

Authors:  Carlos Gustavo V De Moraes; Jeffrey M Liebmann; Robert Ritch; Donald C Hood
Journal:  Arch Ophthalmol       Date:  2012-07

6.  Relationship between short-wavelength automatic perimetry and Heidelberg retina tomograph parameters in eyes with ocular hypertension.

Authors:  Christos Pitsas; Dimitrios Papaconstantinou; Ilias Georgalas; Ioannis Halkiadakis
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

7.  Pattern electroretinogram association with spectral domain-OCT structural measurements in glaucoma.

Authors:  C Bowd; A Tafreshi; L M Zangwill; F A Medeiros; P A Sample; R N Weinreb
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

8.  Novel use of 3T MRI in assessment of optic nerve volume in glaucoma.

Authors:  Norlina M Ramli; Sabrilhakim Sidek; Fadzlina A Rahman; Mohammadreza Peyman; Mimiwati Zahari; Kartini Rahmat; Norlisah Ramli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-27       Impact factor: 3.117

9.  Retinal nerve fiber structure versus visual field function in patients with ischemic optic neuropathy. A test of a linear model.

Authors:  Donald C Hood; Susan Anderson; Jacinthe Rouleau; Adam S Wenick; Larissa K Grover; Myles M Behrens; Jeffrey G Odel; Andrew G Lee; Randy H Kardon
Journal:  Ophthalmology       Date:  2007-09-17       Impact factor: 12.079

10.  Scan tracking coordinates for improved centering of Stratus OCT scan pattern.

Authors:  Gianmarco Vizzeri; Christopher Bowd; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill
Journal:  J Glaucoma       Date:  2009-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.